Study of levocetirizine in seasonal allergic rhinitis

Current Medical Research and Opinion

Volumn 26, Issue 6, 2010, Pages 1269-1275

  Mansfield, Lyndon E ^a   Hampel, Frank ^b   Haeusler, Jean Marc C ^c   Georges, George ^d  

^a Texas Tech University Health Sciences Center El Paso   (United States)

^b Central Texas Health Research   (United States)

^c UCB Inc   (Switzerland)

^d SANOFI   (France)

Author keywords

Allergic rhinitis; Antihistamines; Levocetirizine; Randomized controlled trial; Seasonal; Treatment efficacy

Indexed keywords

LEVOCETIRIZINE; PLACEBO;

ADULT; AGED; ALLERGIC RHINITIS; ARTICLE; BACKACHE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG RESPONSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; DRY NOSE; FATIGUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NOSE DISEASE; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; XEROSTOMIA;

ADOLESCENT; ADULT; AGED; CETIRIZINE; DOUBLE-BLIND METHOD; FEMALE; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; MALE; MIDDLE AGED; RHINITIS, ALLERGIC, SEASONAL; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77952516624     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007991003745233     Document Type: Article

References (14)

1. Bridgewater NJ, Smyrna GA: sanofi-aventis U.S. LLC and UCB Inc. 2009
2. Gillard M, Christophe B, Wels B, et al. H1 antagonists: receptor affinity versus selectivity. Inflamm Res 2003;52(Suppl. 1):S49-50
3. Grant JA, Riethuisen JM, Moulaert B, et al. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofena-dine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects. Ann Allergy Asthma Immunol 2002;88:190-197
4. Bachert C, Bousquet J, Canonica GW, et al. Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis. J Allergy Clin Immunol 2004;114:838-844
5. Segall N, Gawchik SM, Georges G, et al. Efficacy and safety of levocetirizine in improving symptoms and health-related quality of life in US adults with seasonal allergic rhinitis: a randomized, placebo-controlled study. Ann Allergy Asthma Immunol 2010;104:259-267
6. Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 1991;21:77-83
7. Juniper EF, Guyatt GH, Griffith LE, et al. Interpretation of rhinoconjunctivitis quality of life questionnaire data. J Allergy Clin Immunol 1996;98:843-845
8. Reilly M, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 1992; 4:353-365
9. Reilly MC, Tanner A, Meltzer EO. Work, classroom and activity impairment instruments: validation studies in allergic rhinitis. Clin Drug Investig 1996; 11:278-288
10. Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 1991;14:540-545
11. Johns MW. Reliability and factor analysis of the Epworth Sleepiness Scale. Sleep 1992;15:376-381
12. Gawchik SM, Segall N, Georges G, et al. Randomized, placebo-controlled multicenter trial evaluating the effects of levocetirizine on symptoms, work productivity and daytime sleepiness in US adults with seasonal allergic rhinitis [abstract]. Presented at: Western Society of Allergy, Asthma and Immunology (WSAAI), Maui, HI, January 25-29, 2009
13. Segall N, Gawchik SM, Georges G, et al. The efficacy, safety, and impact on health-related quality of life (HRQoL) of levocetirizine in US adults with seasonal allergic rhinitis [abstract]. Presented at: Southwest Allergy Forum (SWAF), Puerto Vallarta, Mexico, January 14-18, 2009
14. Temple R, Ellenberg SS. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: ethical and scientific issues. Ann Intern Med 2000;133:455-463